Literature DB >> 11591325

Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency.

M Yan1, J R Brady, B Chan, W P Lee, B Hsu, S Harless, M Cancro, I S Grewal, V M Dixit.   

Abstract

BLyS (also called BAFF, TALL-1, THANK, and zTNF4), a TNF superfamily member, binds two receptors, TACI and BCMA, and regulates humoral immune responses [1-7]. These two receptors also bind APRIL [7-10], another TNF superfamily member. The results from TACI(-/-) and BCMA(-/-) mice suggest the existence of additional receptor(s) for BLyS. The TACI knockout gives the paradoxical result of B cells being hyperresponsive, suggesting an inhibitory role for this receptor [11, 12], while BCMA null mice have no discernable phenotype [13]. Here we report the identification of a third BLyS receptor (BR3; BLyS receptor 3). This receptor is unique in that, in contrast to TACI and BCMA, BR3 only binds BLyS. Treatment of antigen-challenged mice with BR3-Fc inhibited antibody production, indicating an essential role for BLyS, but not APRIL, in this response. A critical role for BR3 in B cell ontogeny is underscored by our data showing that the BR3 gene had been inactivated by a discrete, approximately 4.7 kb gene insertion event that disrupted the 3' end of the BR3 gene in A/WySnJ mice, which lack peripheral B cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11591325     DOI: 10.1016/s0960-9822(01)00481-x

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  122 in total

1.  The buzz about BAFF.

Authors:  David L Vaux
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

Review 2.  Peripheral B cell selection and homeostasis.

Authors:  Michael P Cancro; Susan Harless Smith
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

3.  Impaired IgA class switching in APRIL-deficient mice.

Authors:  Emanuela Castigli; Sumi Scott; Fatma Dedeoglu; Paul Bryce; Haifa Jabara; Atul K Bhan; Emiko Mizoguchi; Raif S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-26       Impact factor: 11.205

4.  B lymphocyte stimulator levels in systemic lupus erythematosus: higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels.

Authors:  Lauren L Ritterhouse; Sherry R Crowe; Timothy B Niewold; Joan T Merrill; Virginia C Roberts; Amy B Dedeke; Barbara R Neas; Linda F Thompson; Joel M Guthridge; Judith A James
Journal:  Arthritis Rheum       Date:  2011-12

Review 5.  How do follicular dendritic cells interact intimately with B cells in the germinal centre?

Authors:  Chan-Sik Park; Yong Sung Choi
Journal:  Immunology       Date:  2005-01       Impact factor: 7.397

6.  Unexpected development of autoimmunity in BAFF-R-mutant MRL-lpr mice.

Authors:  Zhong L Ju; Gui Y Shi; Jin X Zuo; Jing W Zhang
Journal:  Immunology       Date:  2006-10-31       Impact factor: 7.397

Review 7.  B lymphocyte stimulator protein levels in systemic lupus erythematosus and other diseases.

Authors:  William Stohl
Journal:  Curr Rheumatol Rep       Date:  2002-08       Impact factor: 4.592

8.  Antibody deficiency associated with an inherited autosomal dominant mutation in TWEAK.

Authors:  Hong-Ying Wang; Chi A Ma; Yongge Zhao; Xiying Fan; Qing Zhou; Pamela Edmonds; Gulbu Uzel; Joao Bosco Oliveira; Jordan Orange; Ashish Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-14       Impact factor: 11.205

9.  Global T cell dysregulation in non-autoimmune-prone mice promotes rapid development of BAFF-independent, systemic lupus erythematosus-like autoimmunity.

Authors:  William Stohl; Noam Jacob; William J Quinn; Michael P Cancro; Huaxin Gao; Chaim Putterman; Xiaoni Gao; Luminita Pricop; Michael N Koss
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

10.  Reduced BAFF-R and increased TACI expression in common variable immunodeficiency.

Authors:  Rita R Barbosa; Susana L Silva; Sara P Silva; Alcinda C Melo; M Conceição Pereira-Santos; João T Barata; Lennart Hammarström; Marília Cascalho; Ana E Sousa
Journal:  J Clin Immunol       Date:  2014-05-09       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.